ConductScience.org, home
A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
API referenceFor AI assistants

Trial · NCT03936777

Results by group433

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 433

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)Any ZX008 Open Label Dose75.5percentage of participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 6: Very much improved39Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 6: Much improved88Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 6: Minimally improved87Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 6: No change124Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 6: Minimally worse23Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 6: Much worse7Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 6: Very much worse3Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 12: Very much improved42Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 12: Much improved65Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 12: Minimally improved56Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 12: No change77Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 12: Minimally worse17Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 12: Much worse9Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 12: Very much worse0Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 18: Very much improved34Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 18: Much improved43Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 18: Minimally improved60Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 18: No change67Participants
Clinical Global Impression-Improvement in Participants, Subscale Global: Assessment by Parent/CaregiverAny ZX008 Open Label DoseMonth 18: Minimally worse16Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03936777/results

API referenceFor AI assistants